Meditrina Cyprus Plc
MEDTR | CSE
Overview
Corporate Details
- ISIN(s):
- CY0109701611
- LEI:
- 213800TB7AYEE2DD5Y74
- Country:
- Cyprus
- Address:
- ANEXARTISIAS & ATHINON, 3040 LIMASSOL
- Website:
- https://meditrina.gr/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Meditrina Pharmaceuticals was founded in 2003 by a group of Pharmacists and experienced professionals in the pharmaceutical market. In 2010 Meditrina Pharmaceuticals becomes part of Synapsis group of companies, a pharmaceutical group in Southern Eastern Europe with presence in Greece (Meditrina Pharmaceuticals Ltd), Cyprus (Synapsis Ltd), Romania (Solartium Group Srl), Bulgaria (Synapsis Bulgaria Ltd) and Moldova (Solartium Pharma Srl). Meditrina Pharmaceuticals has offices in Athens and Thessaloniki and 31 employees. There are 4 sales units, covering every major area in the country, with 23 sales reps and 4 unit managers.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-12 10:40 |
Annual / Quarterly Financial Statement
|
Greek (modern) | 3.5 MB | |
| 2025-08-08 08:21 |
M&A Activity
|
English | 294.8 KB | |
| 2025-07-11 09:34 |
M&A Activity
|
English | 1.2 MB | |
| 2025-04-30 06:37 |
Report Publication Announcement
|
Greek (modern) | 268.3 KB | |
| 2025-01-20 15:17 |
Management Discussion and Analysis
|
Greek (modern) | 286.8 KB | |
| 2025-01-15 06:35 |
Registration Form
|
English | 1.1 MB | |
| 2024-12-11 07:05 |
Post-Annual General Meeting Information
|
Greek (modern) | 292.1 KB | |
| 2024-11-05 06:57 |
Interim Report
|
Greek (modern) | 1.1 MB | |
| 2024-05-02 06:04 |
Report Publication Announcement
|
Greek (modern) | 262.4 KB | |
| 2024-01-12 13:03 |
Major Shareholding Notification
|
English | 1.1 MB | |
| 2023-12-21 12:09 |
Management Discussion and Analysis
|
Greek (modern) | 273.3 KB | |
| 2023-12-21 11:32 |
Post-Annual General Meeting Information
|
Greek (modern) | 281.0 KB | |
| 2023-11-28 06:37 |
Pre-Annual General Meeting Information
|
Greek (modern) | 275.2 KB | |
| 2023-10-02 09:05 |
Earnings Release
|
Greek (modern) | 269.6 KB | |
| 2023-08-16 10:46 |
Annual / Quarterly Financial Statement
|
Greek (modern) | 2.1 MB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Nippon Shinyaku Co.,Ltd. | Japan | 4516 | |
|
Noile-Immune Biotech Inc. | Japan | 4893 | |
|
Novartis AG | Switzerland | NOVN | |
|
Nur Ink Innovations Ltd. | Israel | NURI | |
|
Nxera Pharma Co., Ltd. | Japan | 4565 | |
|
ObsEva SA | Switzerland | OBSN | |
|
ODI Pharma AB | Sweden | ODI | |
|
Oncolys BioPharma Inc. | Japan | 4588 | |
|
OncoTherapy Science, Inc. | Japan | 4564 | |
|
OncoZenge AB | Sweden | ONCOZ |